Tag Archive for ‘CompassHER2 Trials’

Tailoring systemic therapy for HER2+ early breast cancer—The CompassHER2 Trials

Summarizes the shared scientific mission of the CompassHER2 Trials, which is to optimize systemic therapy for patients with clinical stage II–III HER2+ early-stage breast cancer.